YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis	CLINICAL ENDOCRINOLOGY
2022	Amivantamab in combination with lazertinib in patients with atypical epidermal growth factor receptor (EGFR) mutations excluding exon 20 insertion mutations: Initial results from CHRYSALIS-2	ANNALS OF ONCOLOGY
2022	Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2022	Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	DIABETES & METABOLISM
2022	Complications related to extracorporeal membrane oxygenation support as a bridge to lung transplantation and their clinical significance	HEART & LUNG
2022	Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis	IN VIVO
2022	First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2022	Nanomedicine for glioblastoma: Progress and future prospects	SEMINARS IN CANCER BIOLOGY
2022	Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)	ANNALS OF ONCOLOGY
2022	Impact of donor hypertension on graft survival and function in living and deceased donor kidney transplantation: a nationwide prospective cohort study	JOURNAL OF HYPERTENSION
2022	Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific	JOURNAL OF MEDICAL VIROLOGY
2022	Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B	LIVER INTERNATIONAL
2022	A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis	SCIENTIFIC REPORTS
2022	Developing an app-based self-management program for people living with HIV: a randomized controlled pilot study during the COVID-19 pandemic	SCIENTIFIC REPORTS
2022	Dose Optimization of Meropenem in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Cardiac Patients: Pharmacokinetic/Pharmacodynamic Modeling	JOURNAL OF CLINICAL MEDICINE
2022	Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052	ANNALS OF ONCOLOGY
2022	ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib	ANNALS OF ONCOLOGY
2022	Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial	CIRCULATION
2022	EXPLORE-LC: A multi-site real-world evidence research platform for non-small cell lung cancer in Asia-Pacific	ANNALS OF ONCOLOGY
2022	Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition	CLINICAL ENDOSCOPY